Equities

Weed Inc

BUDZ:QBB

Weed Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.0617
  • Today's Change-0.013 / -17.73%
  • Shares traded71.17k
  • 1 Year change-29.49%
  • Beta0.7959
Data delayed at least 15 minutes, as of Jun 14 2024 20:26 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

WEED, Inc. is engaged in the business involving the purchase of land and building commercial grade cultivation centers to consult, assist, manage and lease to licensed dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. The Company, through its subsidiary, Sangre AT, LLC, doing business as Sangre AgroTech, is engaged in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry. Its other subsidiaries include WEED Israel Cannabis Ltd, WEED Australia Ltd, and others.

  • Revenue in USD (TTM)0.00
  • Net income in USD-5.19k
  • Incorporated2014
  • Employees2.00
  • Location
    Weed Inc4920 N Post TrlTUCSON 85750-7111United StatesUSA
  • Phone+1 (610) 358-9430
  • Fax+1 (610) 358-9438
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shuttle Pharmaceuticals Holdings Inc0.00-7.35m7.26m8.00--2.63-----0.4739-0.47390.000.16420.00----0.00-96.75---119.37-------------5.280.2542-------112.71------
Trevena Inc3.14m-40.15m7.34m23.00------2.34-2.71-2.710.2107-0.79990.0904----136,478.30-115.65-55.93-148.14-66.3548.04---1,279.01-3,134.41---15.391.88--847.61-11.4324.93---24.67--
Oragenics Inc20.63k-20.26m7.35m5.00--7.12--356.20-7.98-7.980.00790.58590.0026----4,126.00-258.71-97.60-312.34-106.24-----98,214.93-36,169.75----0.0461---71.37---44.56--51.64--
Cyclerion Therapeutics Inc0.00-10.95m7.36m1.00--0.6841-----4.380.29040.003.970.00----0.00-95.95-72.70-158.12-86.96-------2,565.62----0.00---100.00--30.98------
Scorpius Holdings Inc9.74m-32.20m7.38m82.00--0.0961--0.757-1.22-1.400.36630.79370.1372--26.56118,815.70-47.81-39.37-58.20-43.1868.56---348.43-1,068.210.2641-198.180.3179--1,789.583.841.96--27.32--
Healthy Extracts Inc2.56m-2.76m7.41m----48.86--2.89-0.9512-0.95120.88190.05120.94280.503532.10---101.47-53.78-375.65-146.6568.4645.68-107.63-87.530.1293-2.220.879--10.41105.93-151.54------
Chromocell Therapeutics Corp0.00-8.98m7.50m4.00--6.63-----1.66-1.660.000.1960.00----0.00-440.01-----------------7.200.00-------200.20------
Twinlab Consolidated Holdings Inc12.65m-9.55m7.51m17.00------0.5941-0.0369-0.05020.0488-0.54471.011.497.30743,941.20-76.13-60.53----34.5921.36-75.51-37.720.0094-0.0108-----20.87-28.58-20.28------
Weed Inc0.00-5.19k7.62m2.00--70.89194.56---0.00001-0.000010.000.00090.00----0.00-0.4942-385.93-9.56-822.37-----------23.030.5461------97.93---59.13--
Cadrenal Therapeutics Inc-100.00bn-100.00bn7.69m3.00------------------------------------------------------------
National Graphite Corp0.00-1.97m7.72m0.00---------0.0221-0.02210.00-0.01930.00-------11,014.44-212.13---6,295.18---------------------1,432.70------
BioNexus Gene Lab Corp9.78m-2.66m7.81m30.00--0.8357--0.7989-0.14-0.140.6510.52891.018.555.80---27.53-3.83-33.16-5.0213.5614.55-27.25-3.043.98-162.450.00---10.60115.07-638.56--30.40--
Transcode Therapeutics Inc0.00-17.06m7.95m10.00--1.52-----206.36-206.360.000.78930.00----0.00-264.82-133.14-721.90-181.26-----------148.050.00-------5.59------
Allarity Therapeutics Inc0.00-20.94m8.01m5.00---------599.34-599.340.00-18.880.00----0.00-100.46--------------------------3.02------
Psyence Biomedical Ltd0.001.52m8.08m------5.33---0.0442-0.04420.00-0.39790.00------1.13--1.20-----------------------2.63------
Data as of Jun 14 2024. Currency figures normalised to Weed Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.